Method of preventing or treating thrombosis using kappa-caseinog

Details Method of preventing or treating thrombosis using kappa-caseinog Method of preventing or treating thrombosis using kappa-caseinog

1990-05-09

1991-11-05

Lee, Lester L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, 514 21, A61K 3702, C07K 1510, C07K 1514

Patent

active

050632035

ABSTRACT:
The invention relates to the use of .kappa.-caseinoglycopeptide or CGP, in particular from cow's ewe's, goat's or human milk, for the manufacture of a composition, in particular a medicament, for the prevention and/or the treatment of thrombi.
A medicament of this kind can advantageously be presented in lyophilised form intended for injection, after being dissolved in a compatible solvent, or in the form of nanoparticles enclosed in capsules.
Application to the prevention and the treatment of thrombi.

REFERENCES:
patent: 4379142 (1983-04-01), Poet et al.
patent: 4906616 (1990-03-01), Gilchrist et al.
Eur. J. Biochem, 158, 379-382 (1986) Feb. Analogy between fibrinogen and casein, Jolles et al.

Affiliated with

Also associated with

Rating

Method of preventing or treating thrombosis using kappa-caseinog does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of preventing or treating thrombosis using kappa-caseinog, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing or treating thrombosis using kappa-caseinog will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-499303